0001206774-24-000070.txt : 20240201 0001206774-24-000070.hdr.sgml : 20240201 20240201184756 ACCESSION NUMBER: 0001206774-24-000070 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALKEON CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001230239 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41944 FILM NUMBER: 24588327 BUSINESS ADDRESS: STREET 1: 350 MADISON AVENUE STREET 2: 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2127166576 MAIL ADDRESS: STREET 1: 350 MADISON AVENUE STREET 2: 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 3 1 ownership.xml X0206 3 2024-02-01 0 0001999480 Alto Neuroscience, Inc. ANRO 0001230239 ALKEON CAPITAL MANAGEMENT LLC 350 MADISON AVENUE NEW YORK NY 100017 1 0 0 1 See Remarks Series B Preferred Stock Common Stock 392598 D Series C Preferred Stock Common Stock 84503 D Each share of Series B Preferred Stock is convertible at any time, at the holder's election, and will automatically convert into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis into the number of shares of Common Stock shown in column 3 and has no expiration date. Shares held by IJS Global Holdings, Ltd. ("IJS"). The Reporting Person is the investment adviser of IJS, and the Reporting Person disclaims any beneficial ownership of any and all of the Issuer's securities reported herein in excess of its actual pecuniary interest. Each share of Series C Preferred Stock is convertible at any time, at the holder's election, and will automatically convert into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis into the number of shares of Common Stock shown in column 3 and has no expiration date. The Reporting Person may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Po Yu (Jeff) Chen, an employee of the Reporting Person, currently serves on the board of directors of the Issuer. /s/ Alkeon Capital Management, LLC, by Jennifer Shufro, Managing Director 2024-02-01